Tag: diabetes
Study from Ascensia Demonstrates Impact of BGMS Selection on Glycemic Control when Using a Diabetes Management App

Study from Ascensia Demonstrates Impact of BGMS Selection on Glycemic Control when Using a Diabetes Management App

First-of-its-kind data in Ascensia's first ever oral presentation at ATTD, highlights the importance of meter selection for diabetes management apps by assessing accuracy at ...

Lees verder
Ascensia Diabetes Care Celebrates the Important Role Families Play in Supporting People With Diabetes on World Diabetes Day 2019

Ascensia Diabetes Care Celebrates the Important Role Families Play in Supporting People With Diabetes on World Diabetes Day 2019

BASEL, Switzerland, Nov. 14, 2019 /PRNewswire/ -- Today, Ascensia Diabetes Care, a leading global diabetes care company, has launched its campaign for World Diabetes Day 2019 ...

Lees verder
Fiasp® Demonstrated Effective Overall Blood Sugar Reductions in People With Advanced Type 2 Diabetes Uncontrolled on Multiple Daily Injections (B

Fiasp® Demonstrated Effective Overall Blood Sugar Reductions in People With Advanced Type 2 Diabetes Uncontrolled on Multiple Daily Injections (B

BAGSVÆRD, Denmark, Sept. 17, 2019 /PRNewswire/ -- New data presented today at the 55(th) Annual Meeting of the European Association for the Study of Diabetes (EASD) showed ...

Lees verder
Significant Blood Sugar Improvement With Xultophy® Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications

Significant Blood Sugar Improvement With Xultophy® Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications

BAGSVÆRD, Denmark, June 23, 2018 /PRNewswire/ -- Oral Presentation #127-OR Adults with type 2 diabetes treated with Xultophy(R) (insulin degludec and liraglutide injection) ...

Lees verder
Ryzodeg® Significantly Reduces the Risk of Low Blood Sugar in People With Type 2 Diabetes who Fast During Ramadan

Ryzodeg® Significantly Reduces the Risk of Low Blood Sugar in People With Type 2 Diabetes who Fast During Ramadan

ABU DHABI, UAE, December 7, 2017 /PRNewswire/ -- In people with type 2 diabetes who fast during Ramadan, Ryzodeg(R) (insulin degludec/insulin aspart) reduced the overall rate ...

Lees verder
Voluntis to integrate Insulia® with Onduo virtual diabetes clinic

Voluntis to integrate Insulia® with Onduo virtual diabetes clinic

CAMBRIDGE, Massachusetts, Nov. 28, 2017 /PRNewswire/ -- Today, Voluntis announced that it will be integrating Insulia(®) into Onduo's virtual diabetes clinic. Onduo, a new ...

Lees verder
Petitie Diabetes Fonds levert 31.669 handtekeningen op.

Petitie Diabetes Fonds levert 31.669 handtekeningen op.

Petitie Diabetes Fonds levert 31.669 handtekeningen op Consument wil maatregelen om suikerinname terug te dringen Uit handen van Hanneke Dessing, directeur van het Diabetes ...

Lees verder
IDF and Novo Nordisk Launch First-ever Global Survey on Cardiovascular Disease Awareness among People with Type 2 Diabetes

IDF and Novo Nordisk Launch First-ever Global Survey on Cardiovascular Disease Awareness among People with Type 2 Diabetes

BRUSSELS, September 29, 2017 /PRNewswire/ -- - Taking Diabetes to Heart is a global online survey for people with type 2 diabetes to gain important insights ...

Lees verder
Xultophy® Reduces Cardiovascular Risk Factors in People with Type 2 Diabetes

Xultophy® Reduces Cardiovascular Risk Factors in People with Type 2 Diabetes

LISBON, Portugal, September 13, 2017 /PRNewswire/ -- Oral Presentation 113  In people with type 2 diabetes, Xultophy(R) (insulin degludec/liraglutide) significantly reduced a ...

Lees verder
Victoza® Reduces the Risk of Major Cardiovascular Events in People with Type 2 Diabetes With or Without Prior Events

Victoza® Reduces the Risk of Major Cardiovascular Events in People with Type 2 Diabetes With or Without Prior Events

BARCELONA, Spain, August 28, 2017 /PRNewswire/ -- Oral Presentation 3909 A new analysis of the landmark LEADER trial shows that Victoza(R) (liraglutide) reduced the risk of ...

Lees verder
BizPress.nl